Susquehanna International Group’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.3K | Buy |
80,524
+61,771
| +329% | +$18.7K | ﹤0.01% | 6129 |
|
|
2025
Q1 | $5.34K | Sell |
18,753
-30,530
| -62% | -$8.7K | ﹤0.01% | 6249 |
|
|
2024
Q4 | $28.9K | Buy |
49,283
+30,932
| +169% | +$18.1K | ﹤0.01% | 5958 |
|
|
2024
Q3 | $8.19K | Sell |
18,351
-43,470
| -70% | -$19.4K | ﹤0.01% | 5476 |
|
|
2024
Q2 | $164K | Sell |
61,821
-31,600
| -34% | -$83.7K | ﹤0.01% | 4867 |
|
|
2024
Q1 | $256K | Buy |
93,421
+44,243
| +90% | +$121K | ﹤0.01% | 4389 |
|
|
2023
Q4 | $120K | Buy |
49,178
+20,699
| +73% | +$50.3K | ﹤0.01% | 5269 |
|
|
2023
Q3 | $57.5K | Sell |
28,479
-19,060
| -40% | -$38.5K | ﹤0.01% | 5080 |
|
|
2023
Q2 | $140K | Sell |
47,539
-3,178
| -6% | -$9.38K | ﹤0.01% | 4838 |
|
|
2023
Q1 | $127K | Sell |
50,717
-25,667
| -34% | -$64.2K | ﹤0.01% | 5137 |
|
|
2022
Q4 | $242K | Buy |
76,384
+13,581
| +22% | +$43.1K | ﹤0.01% | 4206 |
|
|
2022
Q3 | $187K | Sell |
62,803
-175,258
| -74% | -$522K | ﹤0.01% | 4856 |
|
|
2022
Q2 | $726K | Sell |
238,061
-6,779
| -3% | -$20.7K | ﹤0.01% | 2852 |
|
|
2022
Q1 | $3.31M | Sell |
244,840
-251,035
| -51% | -$3.39M | ﹤0.01% | 1514 |
|
|
2021
Q4 | $6.46M | Buy |
495,875
+263,666
| +114% | +$3.44M | ﹤0.01% | 1019 |
|
|
2021
Q3 | $2.18M | Buy |
232,209
+68,244
| +42% | +$640K | ﹤0.01% | 1876 |
|
|
2021
Q2 | $1.68M | Buy |
+163,965
| New | +$1.68M | ﹤0.01% | 2274 |
|